UC's Eric Vick receives major grants to advance research into combination therapy for leukemia
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from ...
Tag: blood cancer
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "Novel therapy can improve the prognosis of relapsed/refractory acute myeloid leukemia")
Novel therapy can improve the prognosis of relapsed/refractory acute myeloid leukemia
Relapsed/refractory acute myeloid leukemia (AML), a so-called blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs ...
Targeting metabolic pathways to combat Epstein-Barr virus infections
The Epstein-Barr virus can cause a spectrum of diseases, including a range of cancers. Emerging data now show that inhibition ...
Evolving treatment paradigms in multiple myeloma could improve patient outcomes
The , the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a ...
Novel vaccine approach targets AML and other blood cancers
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically ...
City of Hope cures oldest person of blood cancer and achieves HIV remission
City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person ...
MHRA grants conditional marketing authorization for AbbVie's Tepkinly to treat aggressive blood cancer
AbbVie today announced that the UK Medicines and Healthcare products Regulatory Agency has granted conditional Marketing Authorisation for Tepkinly® (epcoritamab) ...
New gene therapy shows promise for treating fusion-driven cancers
A new study presents a promising treatment method for so-called fusion-driven cancers, which are currently often difficult to cure. These ...
Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often ...
,_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "Scientists develop a marker for therapy response in acute myeloid leukemia")
Scientists develop a marker for therapy response in acute myeloid leukemia
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the ...
POPULAR NEWS
